Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.7661
+0.1140 (17.48%)
Nov 18, 2025, 4:00 PM EST - Market closed
Envoy Medical Employees
Envoy Medical had 42 employees as of December 31, 2024. The number of employees increased by 8 or 23.53% compared to the previous year.
Employees
42
Change (1Y)
8
Growth (1Y)
23.53%
Revenue / Employee
$4,952
Profits / Employee
-$681,214
Market Cap
22.05M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42 | 8 | 23.53% |
| Dec 31, 2023 | 34 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COCH News
- 8 days ago - Envoy Medical Reports Third Quarter 2025 Financial and Operational Results - Newsfile Corp
- 14 days ago - Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial - Newsfile Corp
- 20 days ago - Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant - Newsfile Corp
- 22 days ago - Envoy Medical Receives Positive Listing Determination from NASDAQ - Newsfile Corp
- 5 weeks ago - Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 5 weeks ago - Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 6 weeks ago - Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data - Newsfile Corp
- 6 weeks ago - Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data - Newsfile Corp